BioPharma Clinical Trials
APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
APAC Biopharma in Review: What Truly Moved the Needle This Year Asia-Pacific (APAC) has cemented its status as a pivotal biopharmaceutical hub in 2025, ma...
December 15, 2025 | Report
Akeso Secures FDA Clearance to Launch Global Phase III Gastric Cancer Trial of Cadonilimab
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in ...
December 15, 2025 | News
Telix Pharmaceuticals And Varian Enter Strategic Collaboration To Advance Precision Radiation Oncology
Telix Pharmaceuticals Limited announces a strategic clinical collaboration with Varian, a Siemens Healthineers company and global leader in radiation oncol...
December 12, 2025 | News
ProPharma Advances Its India Growth Strategy With Hyderabad Expansion
ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Ody...
December 12, 2025 | News
D3 Bio Secures One Hundred 8M$ In Series B Funding To Advance Global Late Stage Oncology Trials
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completio...
December 11, 2025 | News
Innovent Doses First Participant in Phase One Trial of Novel IL One RAP Antibody for Gout
Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment ...
December 11, 2025 | News
Bringing Multi-Modal Intelligence to Early Clinical Recruitment
A protocol might specify a cohort defined by inflammatory markers, disease severity, a diagnostic pattern or a particular biological signature — but ...
December 10, 2025 | News | By Tom Stubbs, PHD – CEO of Hurdle.bio
SoluPet Partners With CHC To Launch Canine Cognitive Health Solution In Taiwan
SoluPet, the data and science-driven pet cognitive health company developing advanced cognitive-aging support for senior dogs, today announc...
December 10, 2025 | News
Replicate Bioscience Partners With Instituto Butantan To Advance Next Generation srRNA Rabies Vaccine Across Latin America
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunol...
December 05, 2025 | News
Kelun Biotech And Crescent Biopharma Forge Global Partnership To Advance Next Generation Oncology Therapies
Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets an...
December 05, 2025 | News
Antengene Secures Expanded Approvals For Xpovio In Hong Kong Across Multiple Myeloma And DLBCL
- XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the treatment for mul...
December 04, 2025 | News
Aurigene Oncology Reports Strong Early Phase One Results For AUR112 In Relapsed And Refractory Lymphomas
Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology, announced initial clinical results...
December 04, 2025 | News
AdvanCell Launches Theraphase Two Expansion To Optimise Dosing For ADVC001 Across Key Prostate Cancer Settings
Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion will ...
December 04, 2025 | News
Antengene Secures NMPA Approval for IND of CLINCH Two Combination Study in Gastric Cancer
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, develop...
December 03, 2025 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
